NEW YORK (GenomeWeb) – Advanced Cell Diagnostics announced today a preferred partnership agreement with Dundee, UK-based MicroMatrices to develop applications of its RNAscope technology.

ACD's RNAscope assays allow for single RNA molecule detection of formalin-fixed, paraffin-embedded tissue samples, offering quantitative molecular detection with morphological context in a single assay. MicroMatrices has expertise in using RNAscope to detect RNA-based biomarkers in situ, the companies said in a statement, and will now aim to develop preclinical applications of the technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.